Apyx Medical (APYX) Total Liabilities (2010 - 2026)

Apyx Medical (APYX) has reported Total Liabilities for 17 consecutive years, with $50.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 1.48% year-over-year to $50.0 million; the trailing twelve-month figure through Jun 2026 stood at $50.0 million (down 1.48% YoY), and the FY2025 full-year result was $52.0 million, up 2.97% from the prior year.
• Total Liabilities was little changed at $50.0 million in Q2 2026 per APYX's latest filing, from $49.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $52.3 million in Q4 2023 and bottomed at $13.1 million in Q3 2022.
• Historically, Total Liabilities has averaged $37.9 million across 5 years, with a median of $49.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities retreated 4.96% in 2022, then soared 274.18% in 2023.
• Over 5 years, Total Liabilities stood at $14.0 million in 2022, then jumped by 274.18% to $52.3 million in 2023, then dropped by 3.46% to $50.5 million in 2024, then gained by 2.97% to $52.0 million in 2025, then slipped by 3.9% to $50.0 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $50.0 million, $49.9 million, and $52.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.